Last Updated on June 22, 2023

Multiple Sclerosis Journal - Experimental, Translational and Clinical- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: SAGE Publications Inc.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

2.54

SJR

 0.714

h-Index

 25

Rank

 6949

Important Details

Title Multiple Sclerosis Journal - Experimental, Translational and Clinical
Type of Publication Journal
Discipline Neurology (clinical) (Q2); Cellular and Molecular Neuroscience (Q3)
Impact Score 2.54
SCImago Journal Rank (SJR) 0.714
h-index 25
Overall Rank 6949
Publisher Name SAGE Publications Inc.
Publication Country United Kingdom
International Standard Serial Number (ISSN) 20552173
Coverage and History 2015-2022
Best Quartile Q2
Total Citations Received
(Last 3 Year)
477

About Multiple Sclerosis Journal - Experimental, Translational and Clinical


Multiple Sclerosis Journal - Experimental, Translational and Clinical is a journal published by SAGE Publications Inc.. This journal covers the area[s] related to Neurology (clinical), Cellular and Molecular Neuroscience, etc. The coverage history of this journal is as follows: 2015-2022. The rank of this journal is 6949. This journal's impact score, h-index, and SJR are 2.54, 25, and 0.714, respectively. The ISSN of this journal is/are as follows: 20552173.

The best quartile of Multiple Sclerosis Journal - Experimental, Translational and Clinical is Q2. This journal has received a total of 477 citations during the last three years (Preceding 2022).


Multiple Sclerosis Journal - Experimental, Translational and Clinical Impact Score 2022-2023


The latest impact score (IS) of the Multiple Sclerosis Journal - Experimental, Translational and Clinical is 2.54. It is computed in the year 2023 as per its definition and based on Scopus data. 2.54

It is increased by a factor of around 0.31, and the percentage change is 13.9% compared to the preceding year 2021, indicating a rising trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Multiple Sclerosis Journal - Experimental, Translational and Clinical Impact Score 2023


Impact Score 2022 of Multiple Sclerosis Journal - Experimental, Translational and Clinical is 2.54. If a similar upward trend continues, IS may increase in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Multiple Sclerosis Journal - Experimental, Translational and Clinical. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 2.54
2021 2.23
2020 2.33
2019 2.28
2018 1.60
2017 0.98
2016 0.92
2015 0.00

Multiple Sclerosis Journal - Experimental, Translational and Clinical h-index


  Table Setting

The h-index of Multiple Sclerosis Journal - Experimental, Translational and Clinical is 25. By definition of the h-index, this journal has at least 25 published articles with more than 25 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Multiple Sclerosis Journal - Experimental, Translational and Clinical ISSN


The International Standard Serial Number (ISSN) of Multiple Sclerosis Journal - Experimental, Translational and Clinical is/are as follows: 20552173.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Multiple Sclerosis Journal - Experimental, Translational and Clinical Ranking and SCImago Journal Rank (SJR)


The Multiple Sclerosis Journal - Experimental, Translational and Clinical is ranked 6949 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.714.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Multiple Sclerosis Journal - Experimental, Translational and Clinical Publisher


Table Setting

The publisher of Multiple Sclerosis Journal - Experimental, Translational and Clinical is SAGE Publications Inc.. The publishing house of this journal is located in the United Kingdom. Its coverage history is as follows: 2015-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


How to publish in Multiple Sclerosis Journal - Experimental, Translational and Clinical


If your area of research or discipline is related to Neurology (clinical), Cellular and Molecular Neuroscience, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Multiple Sclerosis Journal - Experimental, Translational and Clinical?

The latest impact score of Multiple Sclerosis Journal - Experimental, Translational and Clinical is 2.54. It is computed in the year 2023.


What is the h-index of Multiple Sclerosis Journal - Experimental, Translational and Clinical?

The latest h-index of Multiple Sclerosis Journal - Experimental, Translational and Clinical is 25. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Multiple Sclerosis Journal - Experimental, Translational and Clinical?

The latest SCImago Journal Rank (SJR) of Multiple Sclerosis Journal - Experimental, Translational and Clinical is 0.714. It is calculated in the year 2023.


What is the ranking of Multiple Sclerosis Journal - Experimental, Translational and Clinical?

The latest ranking of Multiple Sclerosis Journal - Experimental, Translational and Clinical is 6949. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Multiple Sclerosis Journal - Experimental, Translational and Clinical?

Multiple Sclerosis Journal - Experimental, Translational and Clinical is published by SAGE Publications Inc.. The publication country of this journal is United Kingdom.


What is the abbreviation of Multiple Sclerosis Journal - Experimental, Translational and Clinical?

This standard abbreviation of Multiple Sclerosis Journal - Experimental, Translational and Clinical is .


Is "Multiple Sclerosis Journal - Experimental, Translational and Clinical" a Journal, Conference or Book Series?

Multiple Sclerosis Journal - Experimental, Translational and Clinical is a journal published by SAGE Publications Inc..


What is the scope of Multiple Sclerosis Journal - Experimental, Translational and Clinical?

The scope of Multiple Sclerosis Journal - Experimental, Translational and Clinical is as follows:

  • Neurology (clinical)
  • Cellular and Molecular Neuroscience

For detailed scope of Multiple Sclerosis Journal - Experimental, Translational and Clinical, check the official website of this journal.


What is the ISSN of Multiple Sclerosis Journal - Experimental, Translational and Clinical?

The International Standard Serial Number (ISSN) of Multiple Sclerosis Journal - Experimental, Translational and Clinical is/are as follows: 20552173.


What is the best quartile for Multiple Sclerosis Journal - Experimental, Translational and Clinical?

The best quartile for Multiple Sclerosis Journal - Experimental, Translational and Clinical is Q2.


What is the coverage history of Multiple Sclerosis Journal - Experimental, Translational and Clinical?

The coverage history of Multiple Sclerosis Journal - Experimental, Translational and Clinical is as follows 2015-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Dermatologia Kliniczna Journal Cornetis 25442 7 0.00
International Journal of Mathematical Education in Science and Technology Journal Taylor and Francis Ltd. 10040 39 1.33
Air and Space Power Journal (discontinued) Journal AU Press 28397 9 0.20
Syntax Journal Wiley-Blackwell Publishing Ltd 3422 29 0.93
Korean Journal of Applied Microbiology and Biotechnology Journal Korean Society for Applied Microbiology 22033 0 0.00
Exploration Geophysics Journal Taylor and Francis Ltd. 16383 48 1.17
Museum Management and Curatorship Journal Routledge 8168 37 2.65
Journal des Professionnels de l'Enfance Journal TPMA 27577 2 0.00
Expert Review of Clinical Pharmacology Journal Taylor and Francis Ltd. 5241 53 4.10
Metascience Journal Springer Nature 13645 3 0.13

Check complete list




Multiple Sclerosis Journal - Experimental, Translational and Clinical Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 2.54
2021 2.23
2020 2.33
2019 2.28
2018 1.60
2017 0.98
2016 0.92
2015 0.00



Top Journals/Conferences in Neurology (clinical)

Lancet Neurology, The
Elsevier Ltd. | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Neuro-Oncology
Oxford University Press | United Kingdom

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neurology, Neurosurgery and Psychiatry
BMJ Publishing Group | United Kingdom

Autism in Adulthood
Mary Ann Liebert Inc. | United States

Sleep Medicine Reviews
Elsevier BV | United Kingdom

Stroke
American Heart Association | United States

European Stroke Journal
SAGE Publications Inc. | United States

Annual Review of Vision Science
Annual Reviews Inc. | United States

See All

Top Journals/Conferences in Cellular and Molecular Neuroscience

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Molecular Psychiatry
Nature Publishing Group | United Kingdom

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Translational Neurodegeneration
BioMed Central Ltd. | United Kingdom

Journal of Neuroinflammation
BioMed Central Ltd. | United Kingdom

Acta neuropathologica communications
BioMed Central Ltd. | United Kingdom

GLIA
John Wiley & Sons Inc. | United States

Cellular and Molecular Life Sciences
Birkhauser Verlag Basel | Switzerland

Cell Death and Disease
Nature Publishing Group | United Kingdom

Translational Psychiatry
Nature Publishing Group | United Kingdom

npj Parkinson's Disease
Springer Nature | United States

PLoS Computational Biology
Public Library of Science | United States

Cerebral Cortex
Oxford University Press | United Kingdom

See All